Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

26.27
Delayed Data
As of Dec 02
 +1.96 / +8.06%
Today’s Change
14.84
Today|||52-Week Range
35.15
-15.18%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close24.31
Today’s open24.22
Day’s range23.85 - 26.75
Volume275,531
Average volume (3 months)234,510
Market cap$915.1M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-143.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.52+2.64%
LCILannett Company Inc+0.60+2.54%
ACORAcorda Therapeutics ...+0.05+0.25%
CORTCorcept Therapeutics...+0.05+0.63%
Data as of 4:01pm ET, 12/02/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs